Product

Deucravacitinib

Image Product Name API Name Last Drug Patent Expires Details Year of start producing
CAS No. 6228-73-5, Deucravacitinib intermediate CAS No. 6228-73-5, Deucravacitinib intermediate Deucravacitinib 11/7/2033 (Deucravacitinib) View detail »
CAS No. 1352925-63-3, Deucravacitinib intermediate CAS No. 1352925-63-3, Deucravacitinib intermediate Deucravacitinib 11/7/2033 (Deucravacitinib) View detail » 2023
CAS No. 372118-00-8, Deucravacitinib intermediate CAS No. 372118-00-8, Deucravacitinib intermediate Deucravacitinib 11/7/2033 (Deucravacitinib) View detail » 2022
CAS No. 1609393-89-6, Deucravacitinib intermediate CAS No. 1609393-89-6, Deucravacitinib intermediate Deucravacitinib 11/7/2033 (Deucravacitinib) View detail » 2023
CAS No. 679406-03-2, Deucravacitinib intermediate CAS No. 679406-03-2, Deucravacitinib intermediate Deucravacitinib 11/7/2033 (Deucravacitinib) View detail »
CAS No. 1609394-10-6, Deucravacitinib intermediate CAS No. 1609394-10-6, Deucravacitinib intermediate Deucravacitinib 11/7/2033 (Deucravacitinib) View detail » 2023
CAS No. 7436-22-8, Deuterium source CAS No. 7436-22-8, Deuterium source Deucravacitinib 11/7/2033 (Deucravacitinib) View detail » 2018